Avoca to Unveil Two New Technology Platforms at the 2018 Global Quality Summit in Dublin, Ireland

PRINCETON, N.J.–(BUSINESS WIRE)–The Avoca Group announced today that it will unveil the Diligent™
Qualification Platform as well as eLuminate™, an e-learning platform, at
the 7th Annual Global Quality Summit 13-14 June 2018, at the
Hotel Intercontinental in Dublin, Ireland.

Sponsored by the
Avoca Quality Consortium™ (AQC)
, a Member-based collaborative
committed to improving outsourced clinical trials, the AQC Global
Quality Summit will offer two insightful days of high-quality analyses
and discussions focused on transforming clinical trial execution. The
additional debut of these new technologies contributes to the robust AQC
content planned for the event.

Avoca will present a fit-for-purpose technology to support the Diligent™
Qualification Platform, an innovative shared resource model for
centralized clinical service provider qualification. Diligent™
accelerates the qualification of vendors by providing rapid, intelligent
access to in-depth RFI questionnaires aligned to AQC’s industry-leading
standards. The second phase of Diligent’s release incorporates five new
high-volume functional categories (field monitoring, data management,
medical writing, biostatistics, and Phase I units) with the original
core requirements and seven endpoint generating service categories
(central laboratories, IRT services, central ECG services, medical
imaging services, biomarker laboratories, bioanalytical laboratories,
and clinical outcome assessment providers). By combining all the
platform’s interactions in this new streamlined, user-friendly
electronic format, the long-term benefits of the model are unlocked:
reducing risk and increasing efficiency in the provider qualification,
selection, and management process through data-driven, higher-quality

Avoca will also be releasing the first two courses from eLuminate™, the
new e-Learning platform developed by the Company: “Fundamentals of
Quality Oversight” and “Fundamentals of Inspection Preparedness.” The
goal of eLuminate™ courses is to ensure a clear and unified
understanding of subject matter within an organization.

“The Diligent Qualification Platform and eLuminate are examples of how
Avoca has combined our rich Consortium content with technology to bring
high value to the industry,” said Patricia Leuchten, Founder and CEO,
The Avoca Group. “Both platforms were developed at the request of our
[AQC] Members during Quality Summit workshops in years past – and so
it’s fitting that we are unveiling the new tools at the 2018 meeting.”

Attracting close to 150 industry leaders each year, the Summit is
designed to provide attendees with practical knowledge and experience to
incorporate and communicate across their organizations. With over a
dozen interactive sessions and numerous networking opportunities, the
Summit is a chance for C-suite executives and heads of clinical
operations, quality, regulatory, procurement, and innovation to connect,
address challenges, engage with thought leaders, and influence change.
The theme for this year’s event, “Embrace the Present. Own the Future.”,
focuses on today’s most innovative solutions for driving efficiency,
improving quality, and mitigating risk in outsourced clinical trials.

This year’s Summit is supported by Platinum-level sponsor ICON,
Gold-level sponsor Purdue Pharma, and Silver-level sponsors Longboat
Clinical and Appian Corporation. Additional sponsorship opportunities
are available; interested companies can access the Sponsorship
for more information.

The Diligent™ Qualification Platform and eLuminate™ will be available to
both AQC Member and Non-member companies in the industry. For more
information, contact Beth Listhaus at beth.listhaus@theavocagroup.com.

Embrace the Present. Own the Future. Learn more about the Summit at theavocagroup.com/quality-consortium/7th-annual-summit.

About The Avoca Quality Consortium

The Avoca Quality Consortium is a Member-based pre-competitive
collaborative comprised of clinical operations, quality, and outsourcing
professionals from pharma, biotech, CROs, and clinical service
providers. The AQC was founded in 2011, and Members include more than 80
pharma, biotech, and clinical service providers.

Through the Knowledge Center, a comprehensive and proprietary repository
of over 400 leading practices, guidelines, tools, templates, and process
documents, as well as AQC research and archived webinars, the AQC
delivers thought leadership to guide Member companies in applying
leading-edge approaches to risk management and complying with GxP. Learn
more about the Consortium here.

About The Avoca Group

The Avoca Group is an integrated research and consulting firm providing
survey research, consulting services, and training in the areas of
clinical trial outsourcing, strategic alliances and quality
management. Sponsors of clinical research and clinical research
organizations have benefited from quantitative and qualitative
perception data gathered by The Avoca Group from sites about their
reciprocal working relationships. The company’s focus is to help solve
complex clinical trial challenges and to improve the quality and
efficiency of clinical trial execution. Founded in 1999, the company
works exclusively in the health care industry and has a focus on
clinical research and clinical outsourcing. Learn more about The Avoca
Group at www.theavocagroup.com
and on LinkedIn
and Twitter.


Crossroads B2B Consulting For The Avoca Group
Laura Vepraskas,